Response surface method: A novel strategy to optimize iontophoretic transdermal delivery of thyrotropin-releasing hormone

Pharmaceutical Research

Volumn 13, Issue 4, 1996, Pages 547-552

  Huang, Yi You ^a   Wu, Shian Min ^b   Wang, Cheng Yi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Iontophoretic transdermal delivery; Optimization; Response surface method; Thyrotropin releasing hormone (TRH)

Indexed keywords

BUFFER; PROTIRELIN;

ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; IONIC STRENGTH; IONTOPHORESIS; NONHUMAN; PH; PRIORITY JOURNAL; RABBIT; SKIN PENETRATION; TECHNIQUE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ELECTROPHORESIS; EPIDERMIS; HYDROGEN-ION CONCENTRATION; IONTOPHORESIS; LINEAR MODELS; OSMOLAR CONCENTRATION; RABBITS; SKIN ABSORPTION; SURFACE PROPERTIES; THYROTROPIN-RELEASING HORMONE;

EID: 0029986924     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016089819967     Document Type: Article

References (12)

1. P. Wehrle, P. Nobelis, A. Cuine, and A. Stamm. Response Surface Methodology: An Interesting Statistical Tool for process Optimization and Validation: Example of Wet Granulation in a High-Shear Mixer. Drug Dev. Ind. Pharm., 19:1637-1653 (1993).
2. D. Vojnovic, M. Moneghini, and F. Rubessa. Optimization of Granulation in a High Shear Mixer by Mixture Design. Drug Dev. Ind. Pharm., 20:1035-1047 (1994).
3. B. Iskandarani, J. H. Clair, P. Patel, P. K. Shiromani, and R. E. Dempski, R.E., Simultaneous Optimization of Capsule and Tablet Formation Using Response Surface methodology. Drug Dev. Ind. Pharm., 19:2089-2101 (1993).
4. E. Senderak, H. Bonsignore, and D. Mungan. Response Surface methodology as an Approach to Optimization of an Oral Solution. Drug Dev. Ind. Pharm., 19:405-424 (1993).
5. Y. Y. Huang, S. M. Wu, C. Y. Wang, and T. S. Jiang. A strategy to optimize the operation conditions in iontophoretic transdermal delivery of pilocarpine, Drug Dev. Ind. Pharm., 21:1631-1648 (1995).
6. P. Wehrle and A. Stamm. Statistcal tools for process control and quality improvement in the pharmaceutical industry. Drug Dev. Ind. Pharm., 20:141-164 (1994).
7. Y. Y. Huang and S. M. Wu. Transdermal iontophoretic delivery of thyrotropin releasing hormone across excised rabbit pinna skin, Drug Dev. Ind. Pharm., 21: in press (1996).
8. M. Corbo, P. R. Wang, J. K. Li, and Y. W. Chien. Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: relationship of pharmacokinetics and pharmacodynamics. J. Pharmacokinetics and Biopharmaceutics, 17:551-570 (1989).
9. R. R. Burnette and D. Marrero. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci., 75:738-743 (1986).
10. J. B. Jaspan, E. Lever, K. S. Polonsky, and E. V. Cauter. In Vivo Pulsatility of Pancreatic Islet Peptides, Am. J. Physiol. 251:E215-E226 (1986).
11. D.S. Weigle. Pulsatile Secretion of Fuel-Regulatory Hormones. Diabetes. 36:764-775 (1987).
12. G. E. Box and N. R. Draper. Emperical model building and response surfaces. Wiley, New York, (1987).